The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Koriagina N.A.

Permskaia gosudarstvennaia meditsinskaia akademiia im. akad. E.A. Vagnera

Petrishcheva A.V.

Permskaia gosudarstvennaia meditsinskaia akademiia im. akad. E.A. Vagnera

The possibility of using anti-atherosclerotic therapy in clinical practice

Authors:

Koriagina N.A., Petrishcheva A.V.

More about the authors

Journal: Russian Journal of Cardiology and Cardiovascular Surgery. 2012;5(4): 31‑35

Read: 920 times

Download PDF (RU)
Contact the author
Table of contents

THE POSSIBILITY OF USING ANTI-ATHEROSCLEROTIC THERAPY IN CLINICAL PRACTICE
THE POSSIBILITY OF USING ANTI-ATHEROSCLEROTIC THERAPY IN CLINICAL PRACTICE

To cite this article:

Koriagina NA, Petrishcheva AV. The possibility of using anti-atherosclerotic therapy in clinical practice. Russian Journal of Cardiology and Cardiovascular Surgery. 2012;5(4):31‑35. (In Russ.)

Подписка 2026 Кардиология и сердечно-сосудистая хирургия (Russian Journal of Cardiology and Cardiovascular Surgery)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
The influence of demo­graphic factors and major como­rbidities on serum circulating regu­latory microRNAs in patients with coro­nary artery athe­rosclerosis and thoracic aortic aneurysm: a single-center cohort study. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(2):174-182
Two years expe­rience of using alirocumab in patients with dyslipidemia. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(2):216-220
10-year dyna­mics of cardiovascular status in combination with coro­nary angiography data in men of working age in the Arctic region of resi­dence and the south of the Tyumen region. Russian Journal of Preventive Medi­cine. 2025;(4):30-38
Study of the levo­carnitine effi­cacy for the treatment of mode­rate cognitive impairment in patients with hype­rtension. Russian Journal of Preventive Medi­cine. 2025;(4):45-50
Triglycerides-Glucose Index as an inte­gral biomarker of insu­lin resi­stance and cardiovascular diseases. Russian Journal of Preventive Medi­cine. 2025;(5):124-129
Contribution of the Russian Academy of Sciences Academician R.G. Oganov to the deve­lopment of the dome­stic preventive cardiology. Russian Journal of Preventive Medi­cine. 2025;(6):7-10
Hype­rtensive diso­rders of pregnancy as a risk factor for chro­nic non-communicable diseases. Russian Journal of Preventive Medi­cine. 2025;(6):114-119
Features of care of patients with cardiovascular diseases and cognitive diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):99-104
Myokines — the cardiometabolic risk pote­ntial biomarkers. Russian Journal of Preventive Medi­cine. 2025;(7):119-126
Recu­rrent coro­nary events as a persistent challenge in cardiology. The role of PCSK9 inhi­bitors in respect of this issue through the example of a local program implemented in St. Pete­rsburg. Russian Journal of Preventive Medi­cine. 2025;(9):78-86
Abstract:

Within 6 months was assessed possible effects most frequently prescribed statin doses most commonly on the atherogenic lipid patients with cardiovascular diseases. Significant difference inreducing total cholesterol and low density lipids in the groups receiving atorvastatin, simvastatin, and rozuvostatin not received. Some what better reduction in atherogenic lipids was observed in the group treated rozuvostatin. Regular monitoring of anti-atherosclerotic therapy has kept commitment to patients around the prescribed treatment, which was manifested in trend toward improved clinical parameters evaluated, and psychological status.

Keywords:

cardiovascular disease
total cholesterol
lipoproteins low-density
statins

Authors:

Koriagina N.A.

Permskaia gosudarstvennaia meditsinskaia akademiia im. akad. E.A. Vagnera

Petrishcheva A.V.

Permskaia gosudarstvennaia meditsinskaia akademiia im. akad. E.A. Vagnera

Close metadata

References:

  1. Belovol A.N., Knyaz'kova I.N. Effektivnost' simvastatina v profilaktike ateroskleroticheskikh zabolevanii. Likaryu-praktiku 2009; 1-2: 13-14.
  2. Bubnova M.G. Sovremennaya profilaktika zabolevanii, svyazannykh s aterosklerozom: vozmozhnosti statinov. Effektivnaya farmakoterapiya 2011; 1: 11-15.
  3. Zeinapur A.A., Bubnova M.G., Perova N.V., Aronov D.M. Vliyanie simvastatina na uroven' lipidov i lipoproteidov krovi natoshchak i posle pishchevoi zhirovoi nagruzki u bol'nykh koronarnoi bolezn'yu serdtsa i giperlipidemiei. Serdtse 2007; 1: 42-43.
  4. Kardiovaskulyarnaya profilaktika. Natsional'nye rekomendatsii. Prilozhenie 2. Kardiovask ter i prof 2011; 6: 64.
  5. Kukharchuk V.V. Lechenie dislipidemii kak vazhnyi faktor profilaktiki ateroskleroza i ego oslozhnenii. Sistemnye gipertenzii 2007; 2: 35-43.
  6. Mareev V.Yu., Danielyan M.O. Krestor: Effektivnost' i bezopasnost' u bol'nykh ishemicheskoi bolezn'yu serdtsa (dizain i osnovnye rezul'taty issledovaniya KEB). Serdtse 2008; 1: 65-70.
  7. Martsevich S.Yu., Kutishenko N.P., Yanusevich V.V. i dr. SAFARI - randomizirovannoe issledovanie po kompleksnoi medikamentoznoi terapii arterial'noi gipertonii i narushenii lipidnogo obmena. Osnovnye rezul'taty. Ratsion farmakoter v kardiol 2009; 1: 51-56.
  8. Pogosova G.V. Depressiya - novyi faktor riska ishemicheskoi bolezni serdtsa i prediktor koronarnoi smerti. Kardiologiya 2002; 4: 86-90.
  9. Sever P., Dalef B., Poulter N. i dr. Potentsial'naya sinergiya gipolipidemicheskogo i gipotenzivnogo lecheniya v anglo-skandinavskom issledovanii iskhodov zabolevanii serdtsa (ASCOT). RMZh 2008; 20: 1306-1311.
  10. Susekov A.V. Vtorichnaya profilaktika ateroskleroza: 30 let primeneniya GMG-KoA-reduktazy. Spravochnik poliklinicheskogo vracha. M 2005; 5.
  11. Susekov A.V. Novye dostizheniya v lechenii giperkholesterinemii i ateroskleroza. Zdorov'e Ukrainy 2008; 1: 42-43.
  12. Susekov A.V., Zubareva M.Yu., Tripoten' M.I. i dr. Randomizirovannoe issledovanie "FARVATER": effekt atorvastatina 10 i 20 mg/sut na uroven' lipidov, S-reaktivnogo belka i fibrinogena u bol'nykh s IBS i dislipidemiei. RMZh 2006; 10: 790-794.
  13. Shal'nova S.A., Deev A.D., Oganov R.G. Faktory, vliyayushchie na smertnost' ot serdechno-sosudistykh zabolevanii v rossiiskoi populyatsii. Kardiovask ter i prof 2005; 1: 4-9.
  14. Shal'nova S.A., Deev A.D. Kharakteristika patsientov vysokogo riska. Rezul'taty epidemiologicheskoi chasti nauchno-obrazovatel'noi programmy OSKAR-2006. RMZh 2007; 9: 757-759.
  15. Effiacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90056 participants in 14 randomised trials of statins. Cholesterol Treatment Trialists (CTT) Collaborators. Lancet 2005; 366: 1267-1278.
  16. Guido F. Guida Summary of the ESC/EAS Guidelines on Dyslipidaemias. Eur Heart J 2011; 32: 14: 1769-1818.
  17. Jones P.H., Davidson M.H., Stein E.A. et al. STELLAR Study Group. Comparsion of the efficacy and safety of rosuvaststin versus atorvastatin, simvastatin and pravastatin across doses (STELLAR trial). Am J Cardiol 2003; 92: 152-160.
  18. Penninx B.W., Beekman A.T., Honig A. et al. Depression and cardiac mortality. Arch Gen Psychiatry 2001; 58: 221-227.
  19. Zigmond A.S., Snaith R.P. The hospital anxiety and depression scale. Acta Psychiat Scand 1983; 67: 6: 361-370.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.